Patient‐reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)

In hematopoietic cell transplantation (HCT), current risk adjustment strategies are based on clinical and disease‐related variables. Although patient‐reported outcomes (PROs) predict mortality in multiple cancers, they have been less well studied within HCT. Improvements in risk adjustment strategies in HCT would inform patient selection, patient counseling, and quality reporting. The objective of the current study was to determine whether pre‐HCT PROs, in particular physical health, predict survival among patients undergoing autologous or allogeneic transplantation.

[1]  L. Jones,et al.  Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study , 2014, Bone Marrow Transplantation.

[2]  N. Geller,et al.  Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  R. Larson,et al.  Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients , 2014, Haematologica.

[4]  J. Liesveld,et al.  Psychosocial factors and hematopoietic stem cell transplantation: Potential biobehavioral pathways , 2013, Psychoneuroendocrinology.

[5]  A. Abernethy,et al.  Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study , 2013, Bone Marrow Transplantation.

[6]  C. Coe,et al.  Biobehavioral influences on recovery following hematopoietic stem cell transplantation , 2013, Brain, Behavior, and Immunity.

[7]  E. Voest,et al.  Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. , 2012, Critical reviews in oncology/hematology.

[8]  H. Deeg,et al.  A disease risk index for patients undergoing allogeneic stem cell transplantation. , 2012, Blood.

[9]  A. Gratwohl.  The EBMT risk score , 2012, Bone Marrow Transplantation.

[10]  M. Clark,et al.  Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Paul K J Han,et al.  Development of a prognostic model for six-month mortality in older adults with declining health. , 2012, Journal of pain and symptom management.

[12]  J. Spertus,et al.  Influence of Frailty and Health Status on Outcomes in Patients With Coronary Disease Undergoing Percutaneous Revascularization , 2011, Circulation. Cardiovascular quality and outcomes.

[13]  M. Sorror.  Comorbidities and hematopoietic cell transplantation outcomes. , 2010, Hematology. American Society of Hematology. Education Program.

[14]  J. Williamson,et al.  Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. , 2010, Blood.

[15]  Qiuling Shi,et al.  Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer , 2009, Cancer.

[16]  Murielle Mauer,et al.  Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. , 2009, The Lancet. Oncology.

[17]  H. Jim,et al.  Quality of life after allogeneic hematopoietic cell transplantation. , 2009, Blood.

[18]  M. Sorror,et al.  Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation , 2008, Cancer.

[19]  W. Larbig,et al.  Pre‐transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation , 2008, Psycho-oncology.

[20]  C. Gotay,et al.  The prognostic significance of patient-reported outcomes in cancer clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. Feeny,et al.  The predictive validity of health-related quality of life measures: mortality in a longitudinal population-based study , 2007, Quality of Life Research.

[22]  D. Esseltine,et al.  Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis. , 2007, Journal of clinical epidemiology.

[23]  Sonali M. Smith,et al.  Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  F. Hoodin,et al.  Do negative or positive emotions differentially impact mortality after adult stem cell transplant? , 2006, Bone Marrow Transplantation.

[25]  L. Ried,et al.  Validating a Self-report Measure of Global Subjective Well-being to Predict Adverse Clinical Outcomes , 2006, Quality of Life Research.

[26]  Muriel Viala,et al.  Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  H. Cohen,et al.  Developing a cancer‐specific geriatric assessment , 2005, Cancer.

[28]  B. Weber,et al.  Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  J. Blanch,et al.  Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Sorror,et al.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. , 2005, Blood.

[31]  B. Storer,et al.  Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. , 2004, JAMA.

[32]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[33]  M. Horowitz,et al.  Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  W. Gianni,et al.  Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  E Graf,et al.  Assessment and comparison of prognostic classification schemes for survival data. , 1999, Statistics in medicine.

[36]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[37]  F. WislØff,et al.  Health‐related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma , 1997, British journal of haematology.

[38]  M. Andrykowski,et al.  Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. , 1994, Psychosomatic medicine.

[39]  K. Sullivan,et al.  Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. , 1993, Bone marrow transplantation.

[40]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[41]  C. Bredeson,et al.  Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center , 2009, Bone Marrow Transplantation.

[42]  D. Fairclough,et al.  Recovery after stem-cell transplantation for hematologic diseases. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  F. Wisløff,et al.  Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. , 1997, British journal of haematology.

[44]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .